JP:4884 Stock Latest News
Company AnnouncementsKringle Pharma Wins FDA IND Clearance for Spinal Cord Injury Drug1w ago4884
Company AnnouncementsKringle Pharma Seeks U.S. Phase 3 Trial for Spinal Cord Injury Drug1M ago4884
Company AnnouncementsKringle Pharma Boosts Sales but Warns of Deeper Full-Year Losses2M ago4884
Company AnnouncementsKringle Pharma Launches Additional Phase 3 Trial of Oremepermin Alfa in Acute Spinal Cord Injury3M ago4884
Company AnnouncementsKringle Pharma narrows revenue gains but deepens losses in first half of FY20265M ago4884
Company AnnouncementsKringle Pharma Posts Narrower Quarterly Loss but Confirms Deep Full-Year Deficit Forecast8M ago4884Company AnnouncementsKringle Pharma Reports Increased Losses and Decline in Financial Position for FY 202511M ago4884
Company AnnouncementsKringle Pharma’s Phase 3 Study on KP-100LI: A Potential Game-Changer for Vocal Fold Scar Treatment1y ago4884
Company AnnouncementsKringle Pharma Expands Global Reach with New U.S. Subsidiary1y ago4884
Company AnnouncementsKringle Pharma Reports Decline in Nine-Month Financial Performance1y ago4884
Company AnnouncementsKringle Pharma’s KP-100IT Receives U.S. FDA Orphan Drug Designation for Spinal Cord Injury1y ago4884- Company AnnouncementsKringle Pharma Reports Financial Decline in First Half of 20251y ago4884
Company AnnouncementsKringle Pharma Releases Updated Analyst Report to Enhance Investor Insight1y ago4884
Company AnnouncementsKringle Pharma Releases Insightful Analyst Report2y ago4884
Company AnnouncementsKringle Pharma Reports Increased Sales Amid Losses2y ago4884